Giorgos Karakousis

12PUBLICATIONS
69CO-AUTHORS
Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 11, 2026
Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

|Dec 11, 2024
Contemporary trends in utilization of metastasectomy in the era of targeted and immunotherapies.

Jesse E Passman, Michael J Kallan, Jeffrey L Roberson

|Sep 30, 2024
An iron-rich subset of macrophages promotes tumor growth through a Bach1-Ednrb axis.

Ian W Folkert, William A Molina Arocho, Tsun Ki Jerrick To

|Sep 09, 2024
Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free Survival.

Kevin L Ma, Tara C Mitchell, Meaghan Dougher

|Jul 22, 2021
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.

Kelly M MacArthur, Brian C Baumann, Joseph F Sobanko

|Apr 07, 2021
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

Kristy Kummerow Broman, Tasha Hughes, Lesly Dossett

Pageof 2

Frequent Collaborators

3 joint publications

Yun Song

2 joint publications

Xiaowei Xu

2 joint publications

Lynn M Schuchter

2 joint publications

Edmund K Bartlett